the use of high-dose Advair for COPD

Glaxo will promote the use of high-dose Advair for COPD.

This is based on a new study comparing the combination of fluticasone and salmeterol (Advair) to salmeterol alone (Serevent).

It shows that high-dose Advair is better than Serevent in reducing exacerbations and the need for systemic steroids.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote